professional documents
home
Upload
docsters
Upload
_-.7s5Lia ,. . December17,200l Food and Drug Administration Office of SpecialNutritionals (HFS-450) Centerof Food Safety and Applied Nutrition 200 C Street,SW Washington,DC 20204 Subject:Nutritional supplementlabelingstatements Dear Sir or Madam, Pursuantto Section 403 ( r)(6) of the Federal Food, Drug and Cosmetic Act, and FDA regulation 21 CFR 101.93, TerraNorthTM,a marketer of bovine colostrum in tended for use as a dietary supplement, is notifying the departmentthat the following statementsof nutritional support are being incorporatedinto our label for distribution within the next 30days. . s TerraNorthTMColostrum is Nature’ First Food: Rich in proteins and factors that support muscle building, immune systemfunction and gastrointestinal health. Pure Colostrum is gentle enough for the very young, yet has the power, as shown by TerraNorthTM university studiesto supportwhole body well-being. The undersigned certifies that the informationcontainedin this notice is completeand accurateand that TerraNorthIncorporatedhas substantiation the statements truthful and not misleading. that are . Sincflely, /I - CharlesCulbxn CFO TerraNorth,Inc. P.O. Box 5978 Bellingham, WA 98227-5978
flag this doc
23
0
not rated
0
5/9/2008
English
Preview

FDA A fillable

GovernmentDocs 5/4/2008 | 403 | 4 | 0 | legal
Preview

Food and Drug Administration FDA Center for Drug Up

FDADocs 5/9/2008 | 178 | 2 | 0 | legal
Preview

Food and Drug Administration FDA Center for Drug

FDADocs 5/5/2008 | 182 | 1 | 0 | legal
Preview

Food and Drug Administration FDA Center for Drug - 2005

FDADocs 5/9/2008 | 199 | 3 | 0 | legal
Preview

Food and Drug Administration Office of SpecialNutritionals

FDADocs 5/5/2008 | 44 | 0 | 0 | legal
Preview

Irradiation of Food An FDA Perspective

GovernmentDocs 5/4/2008 | 136 | 2 | 0 | legal
Preview

Irradiation of Food An FDA Perspective Packaging

FDADocs 5/8/2008 | 119 | 1 | 0 | legal
Preview

FDA Regulatory Pathway Annual FDA and the Changing

GovernmentDocs 5/4/2008 | 166 | 2 | 0 | legal
Preview

AFFIDAVIT IN TRANSIT FDA

FDADocs 5/9/2008 | 76 | 0 | 0 | legal
Preview

FDA Field Inspections

FDADocs 5/5/2008 | 112 | 0 | 0 | legal
Preview

FDA Organizational Chart

FDADocs 5/8/2008 | 313 | 3 | 0 | legal
Preview

FDA in the International Community

FDADocs 5/9/2008 | 111 | 0 | 0 | legal
Preview

FDA s Accomplishments in 2005

FDADocs 5/9/2008 | 92 | 0 | 0 | legal
Preview

FDA Receipt for Samples

FDADocs 5/9/2008 | 140 | 1 | 0 | legal
Preview

FDA Assistance to Industry

FDADocs 5/9/2008 | 139 | 1 | 0 | legal
Preview

Pfizer DTC Hearing Abstract

FDADocs 5/12/2008 | 142 | 1 | 0 | legal
Preview

ROTARIX Rotavirus Vaccine Live Oral

FDADocs 5/12/2008 | 279 | 1 | 0 | legal
Preview

Section Pharmacological Research of VasoCleaner on Hyperlipidemia and Atherosclerosis

FDADocs 5/12/2008 | 157 | 1 | 0 | legal
Preview

Section Documents regarding a Chinese Patent of the herbal formuIation

FDADocs 5/12/2008 | 159 | 1 | 0 | legal
Preview

Section Toxicological tests of VasoCleaner in Mice and Rats

FDADocs 5/12/2008 | 109 | 2 | 0 | legal
Preview

June Pre Market Notification Letter

FDADocs 5/12/2008 | 122 | 0 | 0 | legal
Preview

Report on toxicity test of Xiwang capsule

FDADocs 5/12/2008 | 228 | 0 | 0 | legal
Preview

August letter to Christopher Weisberg P A

FDADocs 5/12/2008 | 181 | 0 | 0 | legal
Preview

Laboratoires Laphal DRD B P Allauch CEDEX France

FDADocs 5/12/2008 | 265 | 0 | 0 | legal
Preview

Transmittal Letter and July letter to Christopher Weisberg P A

FDADocs 5/12/2008 | 113 | 0 | 0 | legal
 
review this doc